Indeed, the retrospective analysis indicated a high CALR mutation burden between initial CML diagnosis and secondary Ph− MPN diagnosis, regardless of the BCR-ABL1 transcript level. The gene discussed is CALR; the disease is myeloproliferative neoplasm.